Lisa Harding, MD, says ECT, ketamine, TMS, and VNS can work, but evidence on what comes after acute response remains thin.
News|Articles|May 9, 2024
Pharmacogenomics: Sticking to the Evidence Base
Author(s)John J. Miller, MD
Pharmacogenomics at the 2024 APA Annual Meeting.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John. J. Miller, MD, sat down with us at the 2024 American Psychiatric Association Annual Meeting to discuss pharmacogenomics, a topic he is very passionate about.
Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Major Depressive Disorder With Mixed Features: Diagnosis and Treatment
2
FDA Shelves Fast-Track Drug Review Initiative
3
New National Guidance for Managing Medetomidine Intoxication and Withdrawal
4
Oveporexton Now Available: First and Only Orexin Agonist for Narcolepsy Type 1
5